Acquisition Opportunity Elevated Softgels was acquired by CV Sciences in May 2024, indicating access to larger distribution networks, capital backing, and potential cross-sell of hemp/CBD contract manufacturing capabilities to CV Sciences’ existing customer base.

Contract Manufacturing Strength As a full-service softgel, vape cartridge, gummy, and tincture contract manufacturer for hemp/CBD, Elevated Softgels offers custom formulations and wholesale solutions, presenting clear upside for white-label or co-manufacturing partnerships with brands seeking scalable production.

Scale & Revenue Current revenue range of $1M–$10M and a mid-sized team suggests room to grow manufacturing capacity and service larger clients or higher-volume product lines through CV Sciences’ network and financing.

Digital & E‑commerce Readiness Tech stack including AWS, Google Cloud, WordPress/WooCommerce, and Mailchimp indicates strong digital infrastructure for direct-to-consumer or B2B e-commerce initiatives, enabling targeted outreach and scalable order management for prospective clients.

Strategic Fit & Markets Position in hemp/CBD consumables with access to established channels positions potential sales opportunities in nutraceuticals, personalized wellness, and regulatory-compliant product lines, leveraging CV Sciences’ market presence to accelerate client acquisition.